"HIV Core Protein p24" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A major core protein of the human immunodeficiency virus encoded by the HIV gag gene. HIV-seropositive individuals mount a significant immune response to p24 and thus detection of antibodies to p24 is one basis for determining HIV infection by ELISA and Western blot assays. The protein is also being investigated as a potential HIV immunogen in vaccines.
Descriptor ID |
D016655
|
MeSH Number(s) |
D12.776.964.775.350.362.500 D12.776.964.775.562.750.500 D12.776.964.970.600.850.350.362.500 D23.050.327.520.300
|
Concept/Terms |
HIV Core Protein p24- HIV Core Protein p24
- HIV gag Gene Product p24
- HIV Major Core Protein p24
- p24(HIV)
- HIV Protein p24
- p24, HIV Protein
- HTLV-III p24
- HTLV III p24
- p24, HTLV-III
- p24 protein, Human Immunodeficiency Virus
- gag Protein p24, HIV
- HIV p24 Antigen
- p24 Antigen, HIV
|
Below are MeSH descriptors whose meaning is more general than "HIV Core Protein p24".
Below are MeSH descriptors whose meaning is more specific than "HIV Core Protein p24".
This graph shows the total number of publications written about "HIV Core Protein p24" by people in this website by year, and whether "HIV Core Protein p24" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2012 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2017 | 5 | 1 | 6 |
2018 | 4 | 5 | 9 |
2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "HIV Core Protein p24" by people in Profiles.
-
Controlled copper in situ growth-amplified lateral flow sensors for sensitive, reliable, and field-deployable infectious disease diagnostics. Biosens Bioelectron. 2021 Jan 01; 171:112753.
-
Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present a-gal epitopes. Vaccine. 2020 09 29; 38(42):6487-6499.
-
DC Subsets Regulate Humoral Immune Responses by Supporting the Differentiation of Distinct Tfh Cells. Front Immunol. 2019; 10:1134.
-
Interleukin 21 (IL-21)/microRNA-29 (miR-29) axis is associated with natural resistance to HIV-1 infection. AIDS. 2018 11 13; 32(17):2453-2461.
-
Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors. Antiviral Res. 2018 12; 160:165-174.
-
Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1-infected individuals. AIDS. 2018 08 24; 32(13):1793-1802.
-
Comparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV Isolates. J Clin Microbiol. 2018 08; 56(8).
-
Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity. AIDS. 2018 06 19; 32(10):1207-1217.
-
Measurement of Human Immunodeficiency Virus p24 Antigen in Human Cerebrospinal Fluid With Digital Enzyme-Linked Immunosorbent Assay and Association With Decreased Neuropsychological Performance. Clin Infect Dis. 2018 06 18; 67(1):137-140.
-
HIV-1 Promotes the Degradation of Components of the Type 1 IFN JAK/STAT Pathway and Blocks Anti-viral ISG Induction. EBioMedicine. 2018 Apr; 30:203-216.